top of page
    • 2 days ago

The CEO of BioArctic talks Leqembi and what's next in Alzheimer's, Parkinson's, ALS, and more

Gunilla Osswald talks about the global approvals Leqembi has received, she makes the case for a European approval, and talks about what BioArctic has in R&D, including a "BrainTransporter" technology that helps get antibodies into the brain more efficiently.




Comentários

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE

bottom of page